Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson may be about to bring long-running talc cancer lawsuits to an end but, even with an eleven figure price-tag, it's far from the biggest corporate settlement ever agreed, writes Adam Maguire.